Core Viewpoint - Cresco Labs Inc. is set to report its financial results for the full year and quarter ended December 31, 2025 on March 5, 2026, before market opens [1] Financial Reporting - The company will host a conference call and webcast to discuss its financial results and provide further insights [1]

Core Insights - The cannabis industry is rapidly evolving, presenting both opportunities and volatility for marijuana stocks, making education essential for investors [1] - Regulatory changes, tax rules, and state legalization efforts significantly influence cannabis stock movements, often more than traditional earnings reports [2] - Financial literacy is crucial for evaluating marijuana stocks, focusing on metrics like revenue growth, profitability, and debt levels to identify sustainable business models [3] Industry Overview - The cannabis market includes multi-state operators, Canadian licensed producers, international medical cannabis companies, ancillary service providers, and cannabis real estate investment trusts, each with varying risk levels and growth potential [2] - Understanding the operational dynamics of these segments allows investors to assess cannabis stocks based on fundamentals rather than speculation [2] Company Highlights - Green Thumb Industries Inc. is set to report its Q4 and full-year 2025 results on February 25, 2026, after market close [6] - Trulieve Cannabis Corp. operates as a cannabis retailer and will hold a conference call on February 26, 2026, to discuss its financial and operating results [7][10] - Cresco Labs Inc. is expanding its footprint by opening a new dispensary in Tamarac, FL, which is its 31st in Florida and 72nd nationwide, emphasizing its commitment to the largest medical market in the U.S. [10][11]

Industry Overview - The U.S. cannabis sector is evolving in early 2026, presenting both risks and opportunities for investors [1] - Regulatory uncertainty has shifted focus towards efficiency, balance sheet repair, and selective growth among operators [1][2] - Potential federal reforms could significantly reshape industry valuations, prompting investors to be more selective [1][2] Investment Focus - Traders are prioritizing companies with established market positions, improving cash flow, and scalable infrastructure [2] - Multi-state operators are expected to benefit from future regulatory changes, including federal tax treatment and banking access [2] Market Volatility - The cannabis market remains volatile, necessitating disciplined risk management [3] - Many stocks are trading below previous highs, creating opportunities for patient investors [3] - Weaker operators may face challenges if capital markets remain tight, emphasizing the importance of company selection [3] February 2026 Outlook - February 2026 is anticipated to be significant for the sector, influenced by earnings updates, regulatory news, and market sentiment [4] - Investors are looking for stocks that combine scale, brand strength, and improved financial discipline [4] Featured Companies AYR Wellness Inc. (AYRWF) - AYR Wellness is a vertically integrated operator with a growing national footprint, primarily in Florida and other states [6][8] - The company focuses on operational control across the supply chain, allowing adjustments based on market demand [9] - Recent restructuring efforts aim to strengthen liquidity and reduce financial strain, with a focus on cost control and cash flow trends [10][11] Cresco Labs Inc. (CRLBF) - Cresco Labs is a well-established multi-state operator with a strong presence in both medical and adult-use markets [12][14] - The company emphasizes brand consistency and consumer trust, with a dual approach of retail and wholesale operations [15] - Financially, Cresco generates high revenue totals, focusing on improving adjusted EBITDA and operating cash flow [16][17] Glass House Brands Inc. (GLASF) - Glass House Brands operates with a strong focus on California, utilizing large greenhouse facilities for cost-efficient production [18][20] - The company emphasizes operational efficiency and quality control through vertical integration [21] - Financial performance has been uneven due to market challenges, but increased production volumes and potential regulatory improvements could support future growth [22][23]

Industry Overview - The global legal cannabis market is experiencing significant growth, with the US cannabis industry leading the way, making it challenging for other markets to keep pace [2] - The Canadian cannabis market is also expanding, and European markets are growing beyond just tourism [1] - Investors are encouraged to take action now to capitalize on potential returns, emphasizing the importance of having a strategic plan [2] Company Highlights - Verano Holdings Corp. is a vertically integrated multi-state cannabis operator in the US and has recently upsized its revolving credit facility by $100 million, extending its maturity date without additional collateral [4][6] - Green Thumb Industries Inc. reported Q3 2025 earnings with revenue of $291.4 million, a 1.6% increase from the previous year, and a cash balance of $226.2 million [11][14] - Cresco Labs Inc. has entered into an equity distribution agreement with Haywood Securities Inc. to use net proceeds for general corporate purposes, including potential acquisitions [13][14] Financial Performance - Cresco Labs reported a GAAP net income of $23.3 million, or $0.10 per share, with an adjusted EBITDA of $80.2 million, representing 27.5% of revenue [14] - Cash flow from operations for Cresco Labs was $74.1 million, indicating strong operational performance [14]

Industry Overview - The cannabis industry is experiencing a pivotal moment with new laws being passed and more expected to be voted on in 2026, indicating a shift towards normalization similar to over-the-counter medications [1] - Recent trends show a recovery in the cannabis sector, moving from a period of low momentum to increased volatility in trading, which has generated optimism among shareholders [2] Investment Opportunities - Investors are advised to remain vigilant and have a trading plan in place as 2026 approaches, which could present significant profit-taking opportunities [3] - Three marijuana stocks are highlighted as potential assets for investors: Green Thumb Industries Inc., Cresco Labs Inc., and Curaleaf Holdings, Inc. [9] Company Highlights - **Green Thumb Industries Inc.** reported Q3 2025 revenue of $291.4 million, a 1.6% increase year-over-year, with a GAAP net income of $23.3 million, and adjusted EBITDA of $80.2 million, representing 27.5% of revenue [10] - **Cresco Labs Inc.** has expanded its retail presence with the opening of a new dispensary in Tamarac, Florida, marking its 31st location in the state and 72nd nationwide, emphasizing its commitment to the largest medical market in the U.S. [13][14] - **Curaleaf Holdings, Inc.** celebrated the launch of adult-use sales in Maine, expanding its retail locations to five in the state and 161 nationwide, reflecting its mission to enhance access to legal cannabis [14][15]

Core Insights - The U.S. cannabis sector is evolving with regulatory momentum, and strong operators are positioning for long-term growth as of January 2026 [1] Group 1: Trulieve Cannabis Corp. - Trulieve Cannabis Corp. is a leading multistate operator with a dominant presence in Florida and over 190 dispensaries nationwide, supporting strong brand recognition and retail traffic [2][4] - The company emphasizes vertical integration and customer loyalty programs, which contribute to strong repeat customer visits and controlled expansion [2][4] - Financially, Trulieve focuses on stability, generating strong quarterly revenue and maintaining high gross margins, while also producing positive operating cash flow and reducing debt [4] Group 2: Curaleaf Holdings, Inc. - Curaleaf Holdings, Inc. operates approximately 150 dispensaries across key markets such as Florida, Massachusetts, New York, and California, with extensive cultivation and processing facilities [6][8] - The company offers a diverse product portfolio and is expanding internationally, which diversifies revenue sources beyond the U.S. market [6][8] - Despite facing pricing competition and regulatory costs, Curaleaf generates positive operating cash flow and is focusing on cost reductions to stabilize profitability [8] Group 3: Cresco Labs Inc. - Cresco Labs Inc. is known for its branded product strategy and operates in high-value U.S. markets, including Illinois and Pennsylvania, with a strong emphasis on wholesale distribution [9][11] - The company's recent financial performance shows stable quarterly revenue and narrowing net losses, indicating potential stabilization despite industry headwinds [11] - Cresco benefits from improving wholesale demand and may gain from potential federal policy developments that could enhance profitability [11]

Core Viewpoint - Cresco Labs Inc. has opened its 31st dispensary in Florida, named Sunnyside Tamarac, reinforcing its commitment to the state's medical market [1] Group 1: Company Expansion - The new dispensary is located at 6001 N University Drive in Tamarac, Florida [1] - This marks Cresco Labs' 72nd dispensary nationwide [1] Group 2: Market Context - Florida is identified as the largest medical market in the United States [1] - The opening of Sunnyside Tamarac is part of Cresco Labs' long-term strategy to serve patients across Florida [1]

Core Viewpoint - The cannabis industry is poised for significant growth by 2026, especially following the rescheduling of cannabis to a Schedule III substance, which may enhance investor confidence and lead to substantial returns in marijuana stocks [1][2][3]. Industry Overview - The cannabis sector is transitioning towards a more corporate structure, benefiting larger multi-state operators (MSOs) while potentially squeezing out smaller craft and mom-and-pop operators [2][3]. - The new legislation may create opportunities for all players in the market, although concerns remain about the quality of products from larger MSOs compared to smaller growers [3]. Company Highlights - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, cultivating, processing, and distributing cannabis products through dispensaries and home delivery. The company expressed appreciation for the rescheduling of cannabis [4][6]. - **Curaleaf Holdings, Inc.**: Engages in the production and distribution of cannabis products both domestically and internationally. Recently opened its second dispensary in Erie, Pennsylvania, expanding its footprint to 18 stores in the state and 159 nationwide [8][10]. - **Cresco Labs Inc.**: Focuses on cultivating, manufacturing, and selling retail and medical cannabis products in the U.S. and Germany. The CEO highlighted the significance of cannabis being reclassified as a Schedule III substance, marking a cultural turning point for the industry [11][13].

Industry Overview - The cannabis industry is entering a critical growth phase, with 2026 positioned as a pivotal year for long-term investors in marijuana stocks [1] - The legal cannabis market is showing signs of structural improvement driven by policy reform, consolidation, and expanding global demand [1][2] Regulatory Developments - A significant development is the U.S. federal government's move to reschedule marijuana, which is expected to lead to meaningful improvements in profitability for top marijuana stocks [2] - Reduced tax pressure and enhanced transparency are making cannabis stocks more attractive to institutional investors [3] Company Highlights - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, cultivating, processing, and distributing cannabis products. The company welcomed the reclassification of marijuana to Schedule III under the Controlled Substances Act [4][5] - **Curaleaf Holdings, Inc.**: Produces and distributes cannabis products in the U.S. and internationally. Recently relocated its Bradford, Pennsylvania dispensary to a new expanded location in Erie, maintaining a footprint of 18 stores in Pennsylvania and 159 locations nationwide [6][8] - **Cresco Labs Inc.**: Cultivates, manufactures, and sells retail and medical cannabis products in the U.S. and Germany. The CEO highlighted the rescheduling of cannabis as a cultural turning point, reflecting the support of nearly 90% of Americans for some form of cannabis legalization [10]

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs†or the "Company†), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump's action to reschedule cannabis from a Schedule I to Schedule III substance under the Controlled Substances Act. "Today marks the most consequential moment in the history of U.S. cannabis. The decision to move cannabis from Schedule I to Schedule III will be a cultural turning point, ackn. ...